Related Experiment Video
Updated: May 14, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized
Veronica Mericq1, Paulina Salas, Viola Pinto
1Institute of Maternal and Child Research, University of Chile, Santiago, Chile.
Insights
Early steroid withdrawal in pediatric kidney transplant patients significantly improves growth and body composition. This approach enhances lipid profiles and, in prepubertal children, suggests better insulin sensitivity.
Area of Science:
- Pediatric Nephrology
- Immunosuppression Therapy
- Transplantation Medicine
Background:
- Glucocorticoid immunosuppressants hinder growth in pediatric kidney transplant recipients.
- Optimizing post-transplant outcomes requires addressing growth and metabolic complications.
Purpose of the Study:
- To evaluate the impact of early steroid withdrawal (SW) on growth, insulin sensitivity (IS), and body composition (BC) in pediatric kidney transplant patients.
- To compare outcomes between early SW and standard steroid treatment.
Main Methods:
- Prospective, randomized, multicenter study involving pediatric kidney transplant recipients.
- Assessed Insulin-like Growth Factor (IGF)-I, IGF-binding protein 3 (IGFBP3), IS, and BC (DEXA/pQCT) at baseline and 12 months post-transplant.
Main Results:
- Early SW group showed significantly greater height SDS increase compared to steroid control (SC) group (+1.2 vs. +0.60).
- SW patients exhibited improved lipid profiles (lower cholesterol, higher HDL) and reduced trunk fat.
- Prepubertal SW recipients demonstrated lower glycemia, triglycerides, and improved lean mass and insulin sensitivity (lower TyG index).
Conclusions:
- Early steroid withdrawal enhances longitudinal growth, lipid profiles, and body composition in pediatric kidney transplant recipients.
- SW may improve insulin sensitivity in prepubertal recipients, indicated by a reduced triglycerides/glycemia index.
Background:
Glucocorticoid immunosuppressant therapy in pediatric kidney transplant (Tx) recipients does not allow the improvement of growth after Tx.
Objective:
To determine the effect of early steroid withdrawal (SW) on longitudinal growth, insulin sensitivity (IS), and body composition (BC).
Methods:
This was a prospective, randomized, multicenter study in Tx. Insulin-like growth factor (IGF)-I, IGF-binding protein 3 (IGFBP3), IS, and BC (DEXA/pQCT) were determined at baseline and up to 12 months after Tx.
Results:
A total of 30 patients were examined; 14 patients were assigned to the SW group (7 male, 7 female; 12 in Tanner stage I) and 16 patients were assigned to the steroid control (SC) group (10 male, 6 female;12 in Tanner stage I). Their chronological age was 7.8 ± 4.3 years, height was -2.3 ± 0.99 SD scores (SDS), and body mass index -0.3 ± 1.2 SDS. After 1 year, the SW group showed an increase in height SDS (+1.2 ± 0.22 vs. +0.60 ± 0.13 SDS in the SC group, p < 0.02), lower IGFBP3 (p < 0.05), cholesterol (p < 0.05), and higher high-density lipoprotein cholesterol (p < 0.05). SW patients had lower trunk fat with no differences in IS. Only in prepubertal patients, the SW group had lower glycemia (p < 0.05), very low-density lipoprotein cholesterol (p < 0.01), triglycerides (p < 0.05), triglycerides/glycemia index (TyG; p < 0.02), and better lean mass. Both groups showed an improvement in lean mass after kidney Tx.
Conclusions:
SW improved longitudinal growth, lipid profile, and trunk and lean fat in Tx patients. In prepubertal recipients, the decrease in TyG suggests better IS.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Chronic Kidney Disease III: Interprofessional Care

